Innoviva Specialty Therapeutics, Inc.
Irina Elkin is a highly experienced professional in commercial operations and analytics within the pharmaceutical industry. Currently serving as Sr. Director of Commercial Operations at Innoviva Specialty Therapeutics, Inc. since April 2024, Irina's past roles include Head of Portfolio Analytics and Intelligence at Galderma, Senior Director of Commercial Operations & Analytics at Prilenia, and Sr. Director of US Commercial Operations at Apellis Pharmaceuticals. Additionally, Irina held significant positions at GSK, TESARO, Boston Health Economics, Trinity Pharma Solutions/SHYFT Analytics, and InterMed Health Technologies, showcasing a robust track record of leadership and expertise in various operational capacities. Irina's academic credentials include a Master of Science in Chemical Engineering from the Massachusetts Institute of Technology and a Bachelor of Science with Honors in Chemical Engineering from Purdue University.
Innoviva Specialty Therapeutics, Inc.
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company developing and delivering innovative therapies in critical care and infectious disease. Our approved treatments are indicated for use in life-threatening circumstances for seriously ill patients, and our investigational therapies are in development for patients fighting drug-resistant pathogens. Growing antimicrobial resistance to existing therapies represents an urgent threat to global public health, and is directly related to significant mortality rates and longer, more expensive hospital stays. We are proud to work with physicians, nurses, hospital pharmacists and administrators, and all who devote their time to caring for patients.